Stay updated with breaking news from 87837710. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First Trust Direct Indexing L.P. lessened its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 14.0% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,380 shares of the biotechnology company’s stock after selling 711 shares during the quarter. First Trust Direct […]
Kornitzer Capital Management Inc. KS raised its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 0.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 192,663 shares of the biotechnology company’s stock after buying an additional 630 shares during the quarter. […]
Bio-Techne (NASDAQ:TECH – Get Free Report) and Genfit (NASDAQ:GNFT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability. Analyst Ratings This is a summary of current ratings and […]
Shares of Bio-Techne Co. (NASDAQ:TECH – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ten brokerages that are currently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year price […]
UBS Group initiated coverage on shares of Bio-Techne (NASDAQ:TECH – Free Report) in a report published on Thursday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $80.00 price objective on the biotechnology company’s stock. A number of other equities research analysts have also recently weighed in on the stock. KeyCorp cut […]